Table 1.
Period 1 | Period 2 | P | |
---|---|---|---|
Characteristics | |||
N | 56 | 66 | NS |
Age, yr (range) | 28 (23–38) | 34 (23–51) | NS |
Male | 66% | 77% | NS |
ISS | 25 (13–36) | 24 (16–36) | NS |
AAST injury grade | |||
Low (I–II) | 46% | 53% | NS |
High (III–V) | 54% | 47% | |
Treatment | |||
Observation n (%) | 28 (50) | 31 (47) | NS |
SAE n (%) | 2 (4) | 22 (34) | <0.001* |
Splenic surgery n (%) | 26 (46) | 13 (19) | <0.001* |
Splenectomy | 22 | 7 | |
Splenorrhaphy | 3 | 4 | |
Other | 1 | 2 | |
Outcomes | |||
Mortality n (%) | |||
Overall | 8 (14%) | 5 (8%) | NS |
Spleen-related | 5 (9%) | 2 (3%) | NS |
Length of stay (range) | 11 (4–26) | 13 (6–25) | NS |
ICU stay (range) | 2 (1–8) | 2 (1–3) | NS |
PRBC <24 h (range) | 11 (4–26) | 0 (0–4) | 0.01* |
SAE splenic artery embolization, ICU intensive care unit, PRBC packed red blood cells, NS not significant
* Statistically significant